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Abstract
Background: Ureaplasma urealyticum that is the smallest free-living bacterium does not have bacterial cell wall. These organisms
cause different infections in respiratory and urinary tract system in close contact with epithelial cells. The current study aimed to
determine the prevalence of U. urealyticum in endocervical samples of female patients referred to Kowsar hospital in Qazvin, Iran.
Methods: The study was conducted on 232 married females aged 20 - 50 years. According to a gynecologist’s request, genital tract
biopsies were taken from each individual using Dacron swabs. Each swab was placed into 4 mL of the pleural pneumonia-like or-
ganism (PPLO) broth media. Then 25 µL of the suspension was inoculated on the surface of PPLO agar. The remaining broth media
and agar plates were incubated at 35°C in 5% CO2 atmosphere.
Results: Out of 232 tested samples, 87 cases (37.5%) were positive for U. urealyticum and 145 (62.5%) were negative.
Conclusions: Rapid laboratory detection of genitalUreaplasma in pregnant females is very important, mainly because of the ability
of the bacteria to colonize the endocervical lining and cause injury to the fetus
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1. Background
Ureaplasma urealyticum, the smallest free-living bacte-
ria (1), lacks a cell wall and its cell membrane contains
sterols and these features are unique among bacteria (1,
2). Ureaplasma species primarily colonize the mucus of
the respiratory system and the urogenital tract and have
a close relationship with the epithelial cell of their hosts.
These organisms adhere to their own surface organelles to
the mucosal surfaces of the genital tract and are founded
in the cervical mucus and vaginal surfaces of 40% - 80% of
adult females without clinical symptoms (2-4) and there
is a common symbiotic relationship between these organ-
isms and urinary tract organs in healthy people (4-7). Ac-
cording to the studies, the prevalence of this microorgan-
ism in Iran is reported 30% - 40% (8). These organisms
cause different infections in the respiratory system and
urinary tract in close contact with epithelial cells. Col-
onization of microorganisms in genitourinary tract are
more common in young people, the ones with low socioe-
conomic status, sexual activity, multiple sexual partners
(3, 4), concurrent bacterial or protozoan infections (4) and
also the black race (3).
The accession of infection is related to using oral and
vaginal contraceptives, menstrual cycle and pregnancy (3,
4). Ureaplasma urealyticum is known as one of the non-
gonococcal urethritis factors (NGU) (1, 2, 5, 7, 9), acute pro-
statitis and acquired arthritis in males. Also these bacteria
are known as the main cause of infertility, miscarriage, sud-
den abortion, stillbirths, preterm births, chorioamnionitis
(2, 3, 5) and postpartum endometritis in females.
Pneumonia, bacteremia and meningitis (2, 5) can be
mentioned as related diseases in children and neonatal.
According to aggravating condition of pregnant females,
fetuses and neonates it is essential to use antibiotics for
treatment. Tetracycline and quinolones are the drugs
that can be used as a treatment for these bacteria (4, 7)
and they have a moderate sensitivity to macrolides such
as erythromycin, clarithromycin and roxithromycin (4).
For pregnant females, children and infants, tetracycline
should not be used and erythromycin is recommended in-
stead. In the cases that tetracycline and erythromycin are
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not effective, clindamycin, fluoroquinolones and others
macrolides should be utilized (10). The criteria to identify
Ureaplasma spp. in the genus level is based on the colony
form and production of urease .The culture is a golden
standard method to detect Ureaplasma spp. (2, 11) and pro-
duction of urease discussed as a potential virulence factor
(2). Colonies of Ureaplasma spp. are detectable by a diame-
ter of 10 to 50 micrometers and have dark or brown appear-
ance after 48 - 72 hours incubation at 37°C and CO2 5% (2,
3, 9). Other methods to diagnose this bacteria are molecu-
lar methods such as polymerase chain reaction (PCR) (2, 11).
The problems of culture process which reduce the sensitiv-
ity of this method are a sensitivity of organism to drought
and environmental conditions (2, 3), the osmotic changes
and toxic metabolites (3). Considering the fact that the cul-
ture is considered as a standard, valuable and inexpensive
method, designing modified methods to repair errors in
previous experiments is essential.
2. Objectives
In the current study the U. urealyticum species were
grown with changes in the cultivation process. Also the
frequencies of U. urealyticum species were investigated
through clinical specimens and their relationship with
clinical symptoms in patients.
3. Methods
The current study was conducted on 232 female pa-
tients referred to the Kowsar hospital affiliated to Qazvin
University of Medical Sciences in 2012. The population in-
cluded all the married females patients aged 20 - 50 years.
According to the diagnosis of a gynecologist, the subjects
were selected for biopsy after completing the question-
naire and signing the written consent.
Inclusion criteria were as follows:
1. Having vaginal discharge, burning or itching in the
vaginal area;
2. History of infertility;
3. History of miscarriage;
4. History of premature delivery;
Exclusion criteria were as follows:
1. Antibiotic consumption within a month before refer-
ring;
2. Being pregnant;
3. Passing menstrual period;
3.1. Sampling and Sample Transfer
The genital tract biopsies were performed after fitting
disposable and sterile speculum and clearing secretions
by genital swab was conducted under the supervision of a
gynecologist. Two samples were taken from each individ-
ual using Dacron swabs (polystyrene). The first swab, un-
der sterile conditions, was placed into 4 mL of the pleural
pneumonia-like organism (PPLO) broth. Each swab was en-
tered into the endocervix for 1 cm, by applying a little pres-
sure on the cervical mucus wall; it was rotated three times
and taken out without contact with the other points on the
way out. For further culture actions the first swab, under
sterile conditions, will be put in 4 mL of PPLO broth. After
moving several times within the media, it was immediately
stored at 2 - 8°C and cultivated up to 24 hours.
The second swab was used to prepare two smear glass
slides and the other one, as a store slide, was kept at -20°C.
3.1.1. PPLO Broth
The broth media was consisted of culture media
powder (Merck, Germany), 10% yeast extract, 20% de-
complemented horse serum, 10% urea, 10% sucrose, 0.25%
penicillin G, 0.1% amphotericin B and 0.2% phenol red.
3.1.2. PPLO Agar
It was consisted of culture powder manufac-
tured by Merck (Germany), 10% yeast extract, 20% de-
complemented horse serum, 10% urea, 10% sucrose, 0.25%
penicillin G and 0.1%.amphotericin B.
3.1.3. Cultivation and Transition From Broth to Solid Medium
Provided samples inoculated into PPLO broth were
held for 24 hours in the refrigerator. Then for transition to
solid culture under sterile conditions, the swabs were dis-
carded after several moving in the PPLO broth. It was done
to release mucus secretion and epithelial cells attached to
the swabs into the broth. Then the broth was centrifuged
under aseptically conditions for 15 minutes at 2,000 rpm.
The supernatant was discarded under sterile conditions;
0.5 mL broth was added to uniform and dilute possible an-
tibacterial compounds into sediment tubes. After uniform
mixing of the broth medium, 25 µL of the suspension was
inoculated by a loop on the surface of PPLO agar and culti-
vated as points, without spreading on the surface.
3.2. Incubation
The remaining sedimentary and agar plates were incu-
bated in the incubator (Memert, Germany) at 35°C in 5%
CO2 atmosphere.
The broth tubes were checked for change of color from
yellow to purple and the plates were evaluated by an op-
tical microscope (40X) for the presence of berries form
brown or dark colonies. Under the condition of observ-
ing the color change in the broth medium and lack of
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colonies in agar plates, based on the explained method,
the broth cultures were transferred onto agar plates and
the plates were checked again, respectively. The agar plates
were daily checked to observe colonies up to 72 hours.
All samples with berry colonies (Figure 1) and changing
color (Figure 2) were considered positive.
Figure 1. Berry Form Colonies of Ureaplasma urealyticum (40X)
Figure 2. Changing the Broth Medium Color is Observed in the Right Tube
Samples with changing of color in the broth medium
without observing berry form colonies were considered
negative. In microscopic examination, observing berry
form colonies of brown or black color (Figure 1) and con-
firmation of absence of other bacteria together with the
color change of broth medium (Figure 2) was considered
as a positive U. urealyticum culture.
4. Results
Out of 232 samples in the current study, 87 (37.5%) cases
were positive for U. urealyticum, and 145 (62.5%) were nega-
tive. According to the diagnosis of a gynecologist, 18 (7.8%)
cases had a history of infertility, 56 (24.1%) with a history
of abortion, 130 (56%) had signs of irritation or vaginal dis-
charge and 13 (5.6%) had a history of the preterm labor. In
the current study, out of 18 patients with a history of in-
fertility, considering U. urealyticum culture, 7 (38.9%) were
positive; 23 (41.1%) out of 56 patients with a history of abor-
tion, 7 (53.8%) out of 13 patients with a history of preterm
labor and 55 (42.3%) out of 130 patients with signs of irri-
tation, itching and vaginal discharge were positive for U.
urealyticum (Table 1).
As indicated in Table 1, the highest prevalence of U. ure-
alyticum, according to cultural growth results, was among
the patients aged 31 to 40 years; therefore, out of the 102
patients in this age group, 41 (40.2%) were positive.
Table 1. Distribution of Ureaplasma urealyticum Species in Different Age Groups
Age Group, y Frequency (%)
< 30 (n = 48) 22 (9.5)
31 - 40 (n = 102) 41 (17.7)
> 40 (n = 82) 24 (10.3)
Total (n = 232) 87 (37.5)
Most of the patients had vaginitis. Among 130 patients,
55 (42.3%) were positive for U. urealyticum and out of 56 pa-
tients with a history of abortion, 23 (41.1%) were contami-
nated with Ureaplasma spp. (Table 2).
Table 2. Distribution of Ureaplasma spp. Infections Based on Clinical Symptoms
Infection Frequency (%)
Infertility (n = 18) 7 (38.9)
Abortion (n = 56) 23 (41.1)
Vaginitis (n = 130) 55 (42.3)
Preterm labor (n = 13) 7 (53.8)
Total 87
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5. Discussion
Ureaplasma species primarily colonize the mucus of
the respiratory system and urogenital tract and have a
close relationship with their hosts’ epithelial cells. In some
species of Mycoplasma, even the invasion of host cells is
happen and the organism reside intracellularly. Some-
times the intracellular invasion is due to chronic infection
and it enables the organism to evade from immune system
(2).
Rapid laboratory detection of genital Ureaplasma
species in pregnant females is very important, mainly
because of the ability of the bacteria to colonize the endo-
cervical lining and cause injury to the fetus. Epidemiologic
data indicated that the presence of these bacteria in the
genital tract is associated with incidence of infertility,
miscarriage, sudden abortion, stillbirths and preterm
births. Chorioamnionitis and postpartum endometritis
in pregnant females and newborns (2, 11) due to bacterial
infection is generally considered as the gold standard
detection method of genital mycoplasmosis. The localiza-
tion and linking to the host epithelial cells were important
on colonization of Ureaplasma spp. and this importance
led to a new method in this study.
There was no significant difference between age and
accession, but a significant difference was observed in the
mean age of the cases with signs of infertility (34.33%) and
individuals without symptoms of infertility (37.57%) (P =
0.34). Considering the age grouping of patients (Table 3),
it was observed that the percentage of positive cases de-
creased significantly with increasing of age (P = 0.048)
Table 3. Relationship Between Age and the Percentage of Positive Cases
Age Group, y Positive Cases (%)
< 30 (n = 48) 45.8
31 - 40 (n = 102) 40.2
> 40 (n = 82) 29.3
The results of the current study as well as those of other
investigations, particularly those of Amirmozafari et al. (8)
in Tehran, indicated that the prevalence of Ureaplasma spp.
by culture was approximately 31.18%, which was lower than
that of the current study (37.5%). In the current study, the
method of cultivation, only reported the color change of
the broth media .Amirmozafari et al. (11), conducted a sim-
ilar study on 210 patients with clinical symptoms to com-
pare PCR and culture results to detect genital Mycoplasma
spp. It showed that out of 210 samples, 69 (32.9%) had pos-
itive culture or Ureaplasma spp. Furthermore, the highest
prevalence of U. urealyticum was in the age group of 29 - 39
years, consistent with the results of the present study.
Suk-JuKimn et al. (12) conducted a similar study in
South Korea on the endocervical swab samples and re-
ported that out of 709 patients referred for screening ure-
thritis, 22.1% were infected with U. urealyticum, which was
also lower than the current study results (37.5%). The stud-
ies by Ekiel (13) and Baka (14) in which the endocervical
sample swabs were cultured on commercial kits IST2 (the
urea arginin broth) also indicated that the prevalence of
Ureaplasma was 34.1% and 52.9% respectively. The differ-
ence could be due to cultural differences and the methods
used.
Ahmadi et al. (15) performed a study to compare two
methods, cultivation and PCR, in which the prevalence of
Ureaplasma spp. with culture method was reported 32.7%
that was similar to the results of the current study (37.5%).
The study by Dilek Kilic et al. (16) in Turkey, culturing in IST2
media, reported the prevalence of U. urealyticum 48%.
The cause of variability of Ureaplasma spp. prevalence
in different studies maybe due to the different diagnos-
tic procedures and samples ,different media, working on
disparate populations and different geographical and cul-
tural areas . The prevalence of Ureaplasma spp. infection
was higher in people with multiple sexual partners; there-
fore, the high prevalence in the developed countries with
sexual freedom was not unexpected.
Considering the fact that U. urealyticum species are one
of the common factors of non-gonococcal urethritis (NGU)
and urogenital diseases in females and males, the accurate
diagnosis is essential.
The preparation of materials and equipment is neces-
sary for laboratories to detect and treat urogenital diseases
in females and plays an important role in accreditation
and promotion of clinical microbiology.
5.1. Laboratory
The prevalence of Ureaplasma spp. was moderate in
Qazvin, Iran. Considering the importance of these bacte-
ria in pregnant females and the present risks for fetus and
infant, more studies in this field are needed.
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